To elucidate the molecular mechanisms underlying FGF21-mediated suppression of pancreatic cancer progression, we employed an integrated approach combining transcriptomic profiling with computational biology and functional molecular assays. The gene discussed is FGF21; the disease is pancreatic neoplasm.